SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

H.C. Wainwright Reiterates Buy on Fennec Pharmaceuticals, Lowers Price Target to $15

H.C. Wainwright reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price target from $17 to $15.

Benzinga · 05/15/2020 11:36

H.C. Wainwright reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and lowers the price target from $17 to $15.